Abstract Title:

Antagonistic and agonistic effects of tamoxifen: significance in human cancer.

Abstract Source:

Semin Oncol. 1997 Feb;24(1 Suppl 1):S1-71-S1-80. PMID: 9045319

Abstract Author(s):

M A Gallo, D Kaufman

Article Affiliation:

University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08855, USA.

Abstract:

Tamoxifen is a substituted triphenylethylene antiestrogen used in the adjuvant therapy and chemoprevention of breast cancer. The antiestrogenic activity of the compound has been attributed to its metabolism to an active 4-hydroxy derivative and the avid binding of the active metabolite to the estrogen receptor. Receptor binding of the antiestrogen alters the transcriptional activity normally attributed to the estradiol-bound estrogen receptor. Tamoxifen is both an antagonist and an agonist of the estrogen receptor. However, a molecular explanation exists for this apparent paradox. The dual action is a function of the estrogen receptor complex present in a particular cell or tissue. If a cell type requires activating factors 1 and 2 of the estrogen receptor to be functioning concurrently, tamoxifen is antagonistic. However, if a cell or tissue requires only activating factor 1 to interact with transcription factors at the promoter, tamoxifen is agonistic. The implication is that the investigators must understand the fundamental biology of the estrogen receptor complex in a tissue context before one can predict tissue activity of tamoxifen.

Study Type : Review
Additional Links
Problem Substances : Tamoxifen : CK(401) : AC(68)
Adverse Pharmacological Actions : Estrogenic : CK(65) : AC(22)

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.